Future studies are needed to ascertain whether SNAP‐25 could contribute to the diagnostic differentiation in other neurodegenerative diseases or be used for monitoring the response to disease‐modifying treatments for AD. This evidence concerns the gene SNAP25 and Alzheimer disease.